Wednesday, July 12, 2023
Lightbeam Health Solutions, a leader in population health enablement solutions and services, has announced an expanded collaboration with Cardinal Health. The collaboration aims to deliver an increased range of solutions through Cardinal Health's Navista TS, a suite of technology solutions developed to help community oncologists enhance patient treatment outcomes and reduce costs associated with value-based care models.
In July 2023, the Enhancing Oncology Model (EOM) took over the Oncology Care Model (OCM), bringing forth new requirements for participating oncology practices. As part of their extended collaboration, Cardinal Health and Lightbeam Health Solutions are joining forces to strengthen the EOM. This will involve oncology practices embracing two-sided risk and prioritizing electronic Patient-Reported Outcomes (ePROs), health-related social needs screenings (HRSNs), and health equity programs.
Under this expanded agreement, Cardinal Health will enhance its EOM offerings by incorporating Lightbeam's population health analytics application, known as Lightbeam Clinical Services (LCS), as well as their Deviceless Remote Patient Monitoring®.
Patrick Burton, the Senior Vice President of Business Development at Lightbeam Health Solutions, expresses his appreciation for being Cardinal Health's trusted partner in providing population health enablement solutions and capabilities. He emphasizes that with the expanded implementation of Lightbeam's solutions, Cardinal Health's Navista™ TS becomes a comprehensive technology solution for patient-centered oncology care. The collaboration underscores the shared objective of Lightbeam and Cardinal Health to deliver innovative solutions that help healthcare organizations achieve better outcomes and succeed in value-based care.
Cardinal Health's Navista™ TS is a comprehensive technology suite designed to enhance care, reduce administrative burdens, and strengthen financial performance in oncology practices. The partnership initially focused on leveraging Lightbeam's prescriptive artificial intelligence (AI) solution, which identifies high-risk social determinants of health (SDoH) factors contributing to poor patient outcomes and increased emergency department (ED) utilization. Notably, research published in ASCO's Journal of Clinical Oncology demonstrated an 18% reduction in monthly ED visits at a Texas cancer center through the use of this tool.
Amy Valley, PharmD, the Vice President of Clinical Strategy and Technology Solutions at Cardinal Health, highlights that expanding their collaboration with Lightbeam Health will better support community oncologists in efficiently managing their patient population. She cites the promising measurable success observed in community oncology practices that have adopted Lightbeam Health's other value-based care tools and looks forward to how this expansion will further support oncology patients throughout their care journeys.
To learn more about Lightbeam's industry-leading population health solutions, their team invites interested parties to schedule a discussion. For additional information on Cardinal Health's Navista™ Tech Solutions, please visit their website.
